abstract |
The invention relates to the compounds of general formula (I): (see formula I), their preparation process and uses for preventing and/or treating diseases in which VEGFR-3 is involved, cancer and metastases, non-oncological proliferative disease or pathological angiogenesis linked to VEGFR-3, chronic or non-chronic inflammation, infection with microorganisms or autoimmune diseases or rare diseases. |